Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for anesthesia in ureteroscopic holmium laser lithotripsy
ChiCTR2500109236Phase 4Not yet recruiting
- Sponsor
- Mengcheng County No. 1 People's Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in ureterolithiasis (2 arms), sponsored by Mengcheng County No. 1 People's Hospital. Primary endpoint: Subjective sleep quality (sleep diary) score. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on ChiCTR2500109236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109236.